Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5530-5533, October 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ireland, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ireland, C. M.

Activated N-ras Oncogenes in Human Neuroblastoma1

Christine M. Ireland2

Children's Leukemia and Cancer Research Unit, Prince of Wales Children's Hospital, High Street, Randwick 2031, New South Wales, Australia

Fifteen primary neuroblastomas and four bone marrow samples from neuroblastoma patients, representing clinical Stages I to IV, have been screened for mutations in codons 12, 13, and 61 of N-ras. Neuroblastoma DNAs were subjected to the polymerase chain reaction to amplify the relevant sequences and were then hybridized with specific oligonucleotides to locate and identify point mutations.

The results show that one Stage I tumor contained an N-ras gene that was activated by a GC-CG transversion of the first base of codon 61, while in one Stage II tumor, activation of N-ras involved a GC-CG transversion of the first position of codon 13. N-ras activations were not detected in the six Stage III tumors and eight Stage IV tumors that were examined.

1 This investigation was supported by a grant from the National Health and Medical Research Council (Australia).

2 To whom requests for reprints should be addressed.

Received 3/20/89. Revised 6/26/89. Accepted 7/ 6/89.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M A Dyer
Mouse models of childhood cancer of the nervous system
J. Clin. Pathol., June 1, 2004; 57(6): 561 - 576.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Maris and K. K. Matthay
Molecular Biology of Neuroblastoma
J. Clin. Oncol., July 1, 1999; 17(7): 2264 - 2264.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
D J Phillips, J M Benson, J M Pruckler, and W C Hooper
PCR regimen for enhanced specificity and yield of targeted genomic DNA sequences: ras and p53.
Genome Res., August 1, 1992; 2(1): 45 - 50.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.